106 related articles for article (PubMed ID: 7789044)
1. Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment.
Lahtela JT; Mustonen J; Pasternack A
Clin Sci (Lond); 1995 Apr; 88(4):427-32. PubMed ID: 7789044
[TBL] [Abstract][Full Text] [Related]
2. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous and intraperitoneal insulin therapy in diabetic patients on CAPD.
Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
Perit Dial Int; 1996; 16 Suppl 1():S288-91. PubMed ID: 8728209
[TBL] [Abstract][Full Text] [Related]
4. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD.
Nevalainen PI; Lahtela JT; Mustonen J; Taskinen MR; Pasternack A
Perit Dial Int; 1999; 19(2):148-53. PubMed ID: 10357186
[TBL] [Abstract][Full Text] [Related]
5. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal insulin reduces plasma leptin concentration in diabetic patients on CAPD.
Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
Perit Dial Int; 2000; 20(1):27-32. PubMed ID: 10716580
[TBL] [Abstract][Full Text] [Related]
8. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G
Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191
[TBL] [Abstract][Full Text] [Related]
9. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
Quellhorst E
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials.
Almalki MH; Altuwaijri MA; Almehthel MS; Sirrs SM; Singh RS
Clin Invest Med; 2012 Jun; 35(3):E132-43. PubMed ID: 22673316
[TBL] [Abstract][Full Text] [Related]
11. An intraperitoneal insulin regimen for diabetics on continuous cyclic peritoneal dialysis.
Aujla NS; Piraino B; Sorkin MI
ASAIO Trans; 1990; 36(2):119-21. PubMed ID: 2187506
[TBL] [Abstract][Full Text] [Related]
12. High peritoneal permeability predisposes to hepatic steatosis in diabetic continuous ambulatory peritoneal dialysis patients receiving intraperitoneal insulin.
Nevalainen PI; Kallio T; Lahtela JT; Mustonen J; Pasternack AI
Perit Dial Int; 2000; 20(6):637-42. PubMed ID: 11216552
[TBL] [Abstract][Full Text] [Related]
13. [Intraperitoneal insulin therapy combined with continuous ambulatory peritoneal dialysis (CAPD)].
Nevalainen P; Lahtela J; Mustonen J; Pasternack A
Duodecim; 1996; 112(2):89-94. PubMed ID: 10590611
[No Abstract] [Full Text] [Related]
14. Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review.
Tzamaloukas AH; Oreopoulos DG
Adv Perit Dial; 1991; 7():81-5. PubMed ID: 1680463
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal insulin in continuous ambulatory peritoneal dialysis (CAPD): clinical aspects.
Triolo G; Carta Q; Salomone M; Dani F; Passarino G; Boggio Bertinet D; Segoloni GP; Vercellone A
Life Support Syst; 1983; 1 Suppl 1():454-6. PubMed ID: 6400733
[No Abstract] [Full Text] [Related]
16. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
[No Abstract] [Full Text] [Related]
17. Hepatic and peripheral insulin action in chronic renal failure before and during continuous ambulatory peritoneal dialysis.
Heaton A; Taylor R; Johnston DG; Ward MK; Wilkinson R; Alberti KG
Clin Sci (Lond); 1989 Oct; 77(4):383-8. PubMed ID: 2680234
[TBL] [Abstract][Full Text] [Related]
18. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
[TBL] [Abstract][Full Text] [Related]
19. Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes.
Ruotolo G; Micossi P; Galimberti G; Librenti MC; Petrella G; Marcovina S; Pozza G; Howard BV
Metabolism; 1990 Jun; 39(6):598-604. PubMed ID: 2191189
[TBL] [Abstract][Full Text] [Related]
20. Report of a 7 year case-control study of continuous intraperitoneal insulin infusion and subcutaneous insulin therapy among patients with poorly controlled type 1 diabetes mellitus: favourable effects on hypoglycaemic episodes.
van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Bilo HJ; Kleefstra N
Diabetes Res Clin Pract; 2014 Nov; 106(2):256-63. PubMed ID: 25305134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
